PUBLICACIÓN

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy

Logo Open Access

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Duarte J.D. et al.

2024 Clinical Pharmacology and Therapeutics

Pharmacology (Q1), Pharmacology (medical) (Q1)

JCR: 5.5

SJR: 2.127


CITAS

34

DOI

10.1002/cpt.3351

EID

2-s2.0-85197294153

ISSN

0009-9236

EISSN

1532-6535

BIBTEX

@article{Agundez2024,title = {Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC)~for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy},journal = {Clinical Pharmacology and Therapeutics},year = {2024},volume = {116},number = {4},pages = {939-947},author = {Duarte, J.D. and Thomas, C.D. and Lee, C.R. and Huddart, R. and Agundez, J.A.G. and Baye, J.F. and Gaedigk, A. and Klein, T.E. and Lanfear, D.E. and Monte, A.A. and Nagy, M. and Schwab, M. and Stein, C.M. and Uppugunduri, C.R.S. and van Schaik, R.H.N. and Donnelly, R.S. and Caudle, K.E. and Luzum, J.A.}}


AUTORES DE LA UEX